NVO Stock Up on FDA Nod for Wegovy in MASH: More Upside Ahead?
Novo Nordisk surges as Wegovy secures FDA approval for MASH, marking a breakthrough in liver care and expanding its blockbuster reach.
Why Is GoodRx Stock Skyrocketing Monday? - GoodRx Holdings ( NASDAQ:GDRX )
Eligible patients can access Ozempic and Wegovy pens for $499/month via GoodRx. Over the past year, nearly 17 million people sought GLP-1 info on GoodRx, up 22%. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan Stanley, and more.
Company News for Aug 18, 2025
Companies in The News Are: AMAT, ...
Lilly Stock Down 5% This Month: Should You Buy the Dip?
Eli Lilly stock is down 5% this month despite strong Q2 results and raised guidance, as data from a study on the obesity pill orforglipron disappointed.
1 Beaten-Down Stock That Could Soar by the End of the Year
The drugmaker has a major catalyst on the way.
This Healthcare Stock's Bad News Could Create a $10 Billion Opportunity for Competitors
The drugmaker's recent dip could also be a buying opportunity.
3 Fantastic Growth Stocks to Buy in August
Only one of these growth stocks is up big so far in 2025. But all three could be huge winners over the next few years.
Jim Cramer Says Don't Quit Market When It's Frothy: 'Is Widespread Irrationality a Reason To Sell Down in Perfectly Rational Stocks? Absolutely Not' - Eli Lilly ( NYSE:LLY ) , Amazon.com ( NASDAQ:AMZN )
Jim Cramer champions staying invested in a frothy market, citing robust stock narratives that defy the volatility. Froth or not, Cramer spotlights the wisdom in holding onto shares of fundamentally solid companies amidst market irrationality.
Is Eli Lilly Stock a Buy? Here's What the Market Isn't Pricing in Yet.
Viking Therapeutics' dual-formulation obesity drug could be the David to Lilly's Goliath.
A Look Into Eli Lilly Inc's Price Over Earnings - Eli Lilly ( NYSE:LLY )
In the current market session, Eli Lilly Inc. LLY price is at $702.03, after a 2.57% spike. However, over the past month, the stock fell by 9.13%, and in the past year, by 23.93%. Shareholders might be interested in knowing whether the stock is undervalued, even if the company is performing up to ...
What's Going On With Eli Lilly Stock Friday? - Eli Lilly ( NYSE:LLY )
Bank of America keeps Buy rating on Lilly with $900 target. Analysts see little risk of margin hit from GLP-1 pricing. Get the latest proven ETF strategies to target and profit from summer volatility before the next big market swing.
UnitedHealth's Best Day Since 2008, Intel's Best Week Since 1975 - SPDR S&P 500 ( ARCA:SPY )
Major U.S. indices ease from record highs as investors awaited the Trump-Putin meeting and digested weaker consumer sentiment. Dow Jones gained 0.2% above 45,000, lifted by a pharma rally led by UnitedHealth's 14% jump on Berkshire Hathaway stake.
Ralph Alvarez Takes a Bullish Stance: Acquires $500K In Eli Lilly Stock - Eli Lilly ( NYSE:LLY )
On August 14, a substantial insider purchase was made by Ralph Alvarez, Board Member at Eli Lilly LLY, as per the latest SEC filing. What Happened: Alvarez's recent move, as outlined in a Form 4 filing with the U.S. Securities and Exchange Commission on Thursday, involves purchasing 758 shares of ...
Veru Announces Novel Modified-Release Oral Formulation for Enobosarm
VERU unveils a novel modified-release oral enobosarm to enhance fat loss while preserving lean mass in chronic weight loss management.
Will New CEO's Leadership Propel Novo Nordisk's Next Growth Wave?
Maziar Mike Doustdar takes office as NVO's new CEO, bringing a proven global growth record to tackle rising obesity market competition.
Eli Lilly Strikes $1.3 Billion Deal With Superluminal To Develop AI-Driven Obesity Drugs - Novo Nordisk ( NYSE:NVO ) , Eli Lilly ( NYSE:LLY )
Eli Lilly and Co LLY has entered into a $1.3 billion deal with Superluminal Medicines to develop small-molecule drugs through artificial intelligence ( AI ) to treat obesity and other cardiometabolic diseases.
Guidance Watch: 2 Companies Bullishly Raising Forecasts
One company remains at the forefront of the AI frenzy, whereas the other has seen insiders dive in post-earnings.
Why Is Eli Lilly Stock Climbing Thursday? - Eli Lilly ( NYSE:LLY )
UK monthly price for Mounjaro's highest dose to rise from £122 to £330 in September. India's Mounjaro Kwikpen priced from 14,000 to 27,500 rupees per month, depending on dose. See what Wall Street is buying with instant access to ratings on 1,000 top stocks, including Goldman Sachs, Morgan ...
Zacks Investment Ideas feature highlights: IonQ, Hims and Hers, Eli Lilly and TransMedics
Insider moves in IonQ, Hims and Hers, Eli Lilly, and TransMedics reveal bold buys, record sales, and signals worth watching.
Why Eli Lilly Stock Popped Today
The GLP-1 weight loss wars have gone global.
Why Is Viking Therapeutics Stock Gaining Wednesday? - Viking Therapeutics ( NASDAQ:VKTX )
William Blair expects Viking's VENTURE-Oral trial to show nearly 7% placebo-adjusted weight loss. Eli Lilly's trial setback could give Viking an edge in the obesity treatment market. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off →
3 Unusual Insider Transactions you Should Know About
While no single indicator can guarantee a stock's performance, the pattern of insider transactions can provide a powerful glimpse into a company's prospects.
Why Is Biogen Stock Climbing Wednesday? - Biogen ( NASDAQ:BIIB )
Biogen CEO says Novo Nordisk's Alzheimer's success could lead to combined drug trials. Novo Nordisk's late-stage Alzheimer's trial results are expected later this year. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday → Biogen Inc.
Time to Buy Eli Lilly and Other Undervalued Healthcare Stocks?
Eli Lilly, CorMedix and Johnson & Johnson represent a diversified mix of healthcare stocks with bullish catalysts ...
Eli Lilly Board Member Makes $1.01M Stock Purchase - Eli Lilly ( NYSE:LLY )
J. Erik Fyrwald pursuant to authorization on file, Board Member at Eli Lilly LLY, disclosed an insider purchase on August 12, based on a new SEC filing. What Happened: file made a significant move by purchasing 1,565 shares of Eli Lilly as reported in a Form 4 filing with the U.S.
EVP Of Eli Lilly Purchased $634K In Stock - Eli Lilly ( NYSE:LLY )
Daniel Skovronsky, EVP at Eli Lilly LLY, reported an insider buy on August 12, according to a new SEC filing. What Happened: Skovronsky demonstrated confidence in Eli Lilly by purchasing 1,000 shares, as reported in a Form 4 filing with the U.S. Securities and Exchange Commission on Tuesday.
Smart Money Move: David A Ricks Grabs $1.05M Worth Of Eli Lilly Stock - Eli Lilly ( NYSE:LLY )
In a recent SEC filing, it was revealed that David A Ricks, President at Eli Lilly LLY, made a noteworthy insider purchase on August 12,. What Happened: Ricks demonstrated confidence in Eli Lilly by purchasing 1,632 shares, as reported in a Form 4 filing with the U.S.
Novo Nordisk Rises 6% So Far in August: How to Play the Stock
NVO stock climbs nearly 6% in August as Lilly's oral obesity candidate setback pivots investor sentiment toward the former's advancing pipeline.
Nvidia To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Wednesday - Celanese ( NYSE:CE ) , Carlyle Group ( NASDAQ:CG )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Guggenheim cut Eli Lilly and Company LLY price target from $942 to $875.
What's Going On With Eli Lilly Stock Wednesday? - Eli Lilly ( NYSE:LLY )
Texas Attorney General alleges Eli Lilly used illegal incentives like "free nurses" to boost drug sales. The lawsuit cites millions in Medicaid claims tied to improper marketing tactics. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off →
The 3 Things That Matter for Viking Therapeutics Now
Enthusiasm for its weight loss medications is intensifying, and several companies are preparing oral formulations.
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years - Eli Lilly ( NYSE:LLY )
Eli Lilly LLY has outperformed the market over the past 15 years by 8.92% on an annualized basis producing an average annual return of 21.42%. Currently, Eli Lilly has a market capitalization of $577.99 billion.
Why Is Hims & Hers Stock Falling Tuesday? - Hims & Hers Health ( NYSE:HIMS ) , Novo Nordisk ( NYSE:NVO )
Novo Nordisk has filed 14 new lawsuits over Wegovy copies, totaling over 130 cases in 40 states. The FDA deadline for compounding Wegovy copies is May 22, unless shortages exist. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday → Hims & Hers Health Inc.
UK Government, Eli Lilly Partner To Target Obesity Health Gaps - Eli Lilly ( NYSE:LLY )
£85 million program to expand obesity care through digital, community, and pharmacy routes. Funding available UK-wide, with services starting as early as summer 2026. This simple system has nailed 1,000+ post-earnings winners. Get in before Q3 trades take off →
The Zacks Analyst Blog Highlights Pfizer, Novo Nordisk and Eli Lilly
Pfizer beats Q2 estimates with rising oncology sales, new drug launches, and strong Seagen-driven portfolio growth.
Best Stock to Buy: Eli Lilly Stock vs. Novo Nordisk Stock
Investors have a tough choice between these two excellent companies.
1 Reason to Buy Eli Lilly ( LLY ) Stock
There's a reason you might want to hold off on buying Lilly stock.
Cramer Upset With Eli Lilly: 'Come Back And Talk To Me' - Bank Bradesco ( NYSE:BBD ) , Affirm Holdings ( NASDAQ:AFRM )
"ServiceNow longer term I think is fine. Shorter term I think it's going to be under pressure," says Cramer. Jim Cramer says Affirm Holdings is a buy. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →
If You'd Invested $1,000 in Eli Lilly ( LLY ) Stock 5 Years Ago, Here's How Much You'd Have Today
Eli Lilly stock plummeted after its recent earnings report, but it's been a long-term winner for investors.
Why Eli Lilly Stock Popped Today
Eli Lilly stock got cheaper last week. Investors now get a second bite at the delicious GLP-1 apple.
Sanofi, Eli Lilly, Novo Nordisk, AstraZeneca Face Renewed Claims Of Conspiring To Restrict 340B Discounts - AstraZeneca ( NASDAQ:AZN ) , Novo Nordisk ( NYSE:NVO ) , Eli Lilly ( NYSE:LLY ) , Sanofi ( NASDAQ:SNY )
Four drugmakers are accused of coordinating to limit mandated discounts for safety-net clinics. Appeals court says plaintiffs plausibly alleged a price-fixing conspiracy. Get ahead of next week's CPI & PPI with Chris Capre's live trading strategy session this Sunday. Register Now →
Can Eli Lilly Keep Up as NVO Eyes First Oral Obesity Pill Approval?
LLY's orforglipron study results disappoint, shifting investor focus to Novo Nordisk's bid for first FDA-approved oral obesity pill.
Lilly ( LLY ) Reliance on International Sales: What Investors Need to Know
Explore Lilly's (LLY) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock.
Should Pfizer Stock Be in Your Portfolio After Solid Q2 Results?
Pfizer posts strong Q2 earnings and raises EPS outlook, with oncology growth and new drugs offsetting looming headwinds.
Eli Lilly and Company ( LLY ) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Lilly (LLY). This makes it worthwhile to examine what the stock has in store.
Bulls And Bears: AMD, Apple, Eli Lilly - And Wall Street Treads Water Bulls And Bears: AMD, Apple, Eli Lilly - And Wall Street Treads Water - Apple ( NASDAQ:AAPL ) , Advanced Micro Devices ( NASDAQ:AMD )
Benzinga examined the prospects for many investors' favorite stocks over the last week - here's a look at some of our top stories. Wall Street treaded water this week as the Federal Reserve maintained rates at 4.25-4.50% despite mounting pressure.
Why Novo Nordisk Stock Flew Higher on Friday
It looked good next to a company that has been stealing its thunder lately.
Why Eli Lilly Stock Sank 18% This Week
The drugmaker is in a 35% drawdown.
Apple Notches Best Week In Years, Trump Shakes Fed Leadership: This Week In Markets - Apple ( NASDAQ:AAPL ) , Eli Lilly ( NYSE:LLY )
Tech stocks rallied as Apple and Palantir delivered standout earnings-driven gains. Trump escalates tariffs, nominates Fed ally Miran amid monetary policy shifts. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →
Eli Lilly's Orforglipron Data Is Not Disastrous: Analyst - Eli Lilly ( NYSE:LLY )
Orforglipron cut weight by 12.4% vs. 0.9% with placebo, below 15% expectations. BofA lowered Eli Lilly's price forecast to $900 but kept a Buy rating after earnings beat. The next 100%+ earnings move could hit this month. See how to find it live on Wednesday →
